Harvard Bioscience
HBIO
HBIO
64 hedge funds and large institutions have $56.4M invested in Harvard Bioscience in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-4
Holders Change %
-5.88%
% of All Funds
1.41%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
5
Increased
21
Reduced
25
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ECM
Engine Capital Management
New York
|
$10.8M |
2 |
HP
Harvey Partners
Tarrytown,
New York
|
$3.78M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$4.43M |
4 |
Renaissance Technologies
New York
|
$1.5M |
5 |
GC
Globeflex Capital
San Diego,
California
|
$228K |